TP53突变作为胆瘤进展的驱动因素和侵袭性胆瘤的特征
Szymon Baluszek1, Paulina Kober1, Michał Wa̧grodzki2
1Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Acta neuropathologica communications
|December 20, 2025
概括
在瘤进展过程中获得TP53突变,这表明侵略性瘤 (DC和PDC) 的预后更差. TP53测序可以作为这些罕见的,攻击性的癌症的生物标志物.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 不分化胆瘤 (DC) 和差分化胆瘤 (PDC) 是罕见的,具有不良预后的侵袭性胆瘤亚型.
- 驱动这些侵袭性亚型的进展的潜在分子机制尚不清楚.
研究的目的:
- 研究驱动常规胆瘤 (CC) 发展为攻击性亚型 (DC/PDC) 的分子机制.
- 识别潜在的生物标志物,以预测和预测侵袭性冠状瘤的预后.
主要方法:
- 整体外体测序 (WES) 和向测序在初级和复发性心脏瘤样本上进行.
- 分析了基因组变化,包括体质突变和副本数变异.
- 进行了生存分析,以评估发现突变的预后价值.
主要成果:
- 整体外基因组测序揭示了CC到DC进展期间显著的基因组变化,体突变的增加.
- 在进展过程中获得了TP53突变,并且与常规冠状腺瘤 (CC) 相比,在攻击性冠状腺瘤 (DC/PDC) 中明显更频繁.
- TP53突变与具有攻击性冠状瘤的患者的预后明显恶化有关.
结论:
- TP53突变是在瘤进展过程中获得的,并且与具有侵略性的表型有关.
- TP53测序可能作为攻击性胆瘤 (DC/PDC) 的预后和预测生物标志物.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K


